Clinical Trials Directory

Trials / Completed

CompletedNCT07136246

A Prognostic Model for COPD Complicated With Sarcopenic Obesity Based on Bioelectrical Impedance Phase Angle Technology

Research on the Construction of a Prognostic Model for COPD Complicated With Sarcopenic Obesity Based on Bioelectrical Impedance Phase Angle Technology

Status
Completed
Phase
Study type
Observational
Enrollment
200 (actual)
Sponsor
Fudan University · Academic / Other
Sex
All
Age
65 Years
Healthy volunteers
Not accepted

Summary

This study aims to explore the diagnosis, impact, and prognostic factors of COPD complicated with sarcopenic obesity using multi-segment bioelectrical impedance phase angle technology. It seeks to clarify the diagnostic value and efficacy of body composition analysis in specific populations, analyze the relationship between phase angle and COPD severity as well as quality of life, investigate its predictive role for adverse outcomes, and reveal the effects of inflammation and metabolic disorders in sarcopenic obesity. The goal is to provide a basis for early screening and precise intervention to improve patient prognosis.

Detailed description

The primary objective of this study is to use multi-segment bioelectrical impedance phase angle technology to explore the diagnosis, impact, and prognostic factors of COPD complicated with sarcopenic obesity. The study aims to clarify the diagnostic value and efficacy of body composition analysis in specific populations, analyze the relationship between phase angle and COPD severity as well as quality of life, investigate its predictive role for adverse outcomes, and reveal the effects of inflammation and metabolic disorders in sarcopenic obesity. The goal is to provide a basis for early screening and precise intervention to improve patient prognosis.

Conditions

Interventions

TypeNameDescription
DEVICEInBody S10Bioelectrical Impedance Phase Angle Technology Measured via InBody S10 at six frequencies (1kHz-1000kHz) during each follow-up

Timeline

Start date
2025-08-01
Primary completion
2026-01-23
Completion
2026-01-23
First posted
2025-08-22
Last updated
2026-01-26

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT07136246. Inclusion in this directory is not an endorsement.